Maison de Solenn Maison des Adolescents, Cochin Hospital
Paris, IDF, 75014, France
NCT Number: NCT05432323
The purpose of this study is to determine whether multi-family therapy is effective in the treatment of school refusal with anxiety in adolescence.
Looking for future studies?
Notify Me12 year–18 year
All sexes
Observational
Paris, IDF, 75014, France
Anxious school refusal in adolescence is a major public health problem. The involvement of families is essential and multi-family therapy has shown its effectiveness for many mental disorders. This study aims to explore the benefit of multi-family therapy in the care of anxious school refusal in adolescence.
The method will be qualitative with phenomenological analysis of semi-structured interviews with adolescents and their parents and quantitative with a SCED design to assess the evolution of the level of anxiety of adolescents and parents, as well as personalized objectives.
The objective is therefore to improve the care of adolescents with anxious school refusal.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 sessions of Multi-family therapy of 3 hours each during 24 weeks
Time frame: 13 to 15 months
Visual Analogue Scale for anxiety (adolescents and parents) / 0 = no anxiety at all, 10 = maximum anxiety imaginable / Weekly measurement between inclusion and the end of the Single Case Experimental Design (SCED) follow-up (13 to 15 months)
Time frame: 13 to 15 months
School attendance (adolescent) / 3-terminal GAS are 5-level GAS, i.e. with a possible rating ranging from -2 to +2. Level -2 corresponds to the initial state at the time of inclusion. Levels -2, 0 and +2 are precisely described, level -1 corresponds to a rating between -2 and 0 and level +1 to a rating between 0 and +2 / Weekly measurements, parents and adolescent, once a week from inclusion to the end of the SCED follow-up (13 to 15 months)
Time frame: 13 to 15 months
Depression (adolescent) / 10 questions / Monthly measurements, adolescent and referring psychiatrist once a month from inclusion to the end of the SCED follow-up (13 to 15 months)
Time frame: 13 to 15 months
Family functioning / 12 questions, minimum = 12, maximum = 48 / Monthly measurements, parents and adolescent, once a month from inclusion to the end of the SCED follow-up (13 to 15 months)
Time frame: 13 to 15 months
Global Functioning of the adolescent / From 0 = inadequate information, to 100 = higher level of functioning in a wide variety of activities - V-axis of the DSM 5 / Monthly measurements, referring psychiatrist, once a month from inclusion to the end of the SCED follow-up (13 to15 months)
Time frame: 7 to 9 months
Satisfaction of the patients and the parents with multi-family therapy / 8 questions, minimum score = 8, maximum = 32 / At the end of the multifamily therapy, parents and teenager
Time frame: 7 to 9 months
Semi-structured interview with qualitative phenomenological analysis (patients and parents) At the end of multi-family therapy
Time frame: 19 to 21 months
Semi-structured interview with qualitative phenomenological analysis (patients and parents) 12 months after the end of multi-family therapy
Assistance Publique - Hôpitaux de Paris
Other
Acronym: Multi-Fast
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05647499
Absence, Anxiety Disorders
Bergen, Norway
View Trial DetailsNCT03288649
Anorexia Nervosa, Anxiety Disorders
Argenteuil, France
View Trial DetailsNCT07020013
Anxiety Disorders, Mental Disorders
La Penne-sur-Huveaune, France
View Trial DetailsNCT03459677
Anxiety Disorders, Anxiety Symptoms
Aarhus, Denmark
View Trial Details